🇺🇸 FDA
Patent

US 8623330

Emollient foams for treatment of seborrheic dermatitis

granted A61KA61K9/0014A61K9/107

Quick answer

US patent 8623330 (Emollient foams for treatment of seborrheic dermatitis) held by Precision Dermatology, Inc. expires Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Precision Dermatology, Inc.
Grant date
Tue Jan 07 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 02 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
8
CPC classes
A61K, A61K9/0014, A61K9/107, A61K9/122, A61K9/124